The start of Thursday’s session on Wall Street is bringing a slight upward correction, likely a relief rebound after the deep declines of the last few sessions.
The early-session leader is the Russell index, whose futures are up nearly 1%. Beyond the rebound effect, it’s possible the market is seeing pressure on the Fed coming from the labor market as well as low core PPI - so that it does not tighten policy.
- One of the key news items that may define the direction of today’s and tomorrow’s sessions are Donald Trump’s comments regarding Iran. After several weeks of de-escalatory rhetoric, the president is clearly pointing to a high likelihood of a return to bombing Iran.
- Reports from the WSJ indicate that OpenAI may enter a phase of aggressive price war with Anthropic ahead of its IPO.
Macroeconomic data
- In the U.S., key macroeconomic data were published regarding inflation and producer prices.
- Labor market data surprised the market with a moderate deterioration: jobless claims rose from 225k to 229k, versus expectations of a decline to 220k.
- PPI inflation came in mixed. Headline PPI rose above expectations to 6.5%, while core PPI fell below expectations to 4.9%. This suggests that broader economic conditions may be weaker than the market is pricing in, and that the rise in prices has a larger-than-expected energy component.
US100 (D1)
Buyers managed to defend the resistance zone at 28,440, where the 61.8% and 161.8% Fibonacci levels intersect. The 50-day EMA is also located at this level. The EMA momentum structure remains strongly bullish, and RSI has already fallen to around 40, which creates favorable conditions for an upward corrective move. The first target for demand is resistance at the 38.2% Fibonacci level. If gains break down and price falls below the last resistance, the next support for buyers is the 78.6% Fibonacci level, i.e., around 27,500 USD. Source: xStation5
Company news
- Oracle (ORCL.US): The company released results for Q2 FY2026; the share price is down about 8% in after-hours trading. Revenue rose 21% y/y to $19.2 billion, and EPS came in at $2.11. Particularly positive for investors was cloud segment revenue growth of as much as 90%, and receivables increased by 363% y/y. However, strong results were not enough to divert attention from another huge jump in CAPEX. Capital expenditures are now $55.7 billion for the fiscal year.
- Navan (NAVN.US): The company operates an AI platform supporting travel planning and expense settlement. Q2 results showed non-GAAP EPS rising to $0.08, eight times market expectations, while revenue grew to $220 million, up 40% y/y. Most important, however, may be the 50% y/y increase in bookings, which - together with raising the revenue forecast to over $900 million for the fiscal year—has the stock up about 50% in after-hours trading.
- Sandisk (SNDK.US): Oracle’s huge CAPEX weighed on the company’s valuation, but reaffirmed commitments from hyperscalers are supporting valuations of semiconductor and memory manufacturers. Sector gains are in the 4–6% range.
- Firefly Aerospace (FLY.US): Expectations surrounding a SpaceX IPO are supporting valuations of space-sector companies. The stock is up more than 4%.
- Adobe (ADBE.US): The company is set to report results after the session ends. The market expects EPS above $5.8 and revenue around $6.5 billion. Beyond the numbers, the key will also be messaging and guidance, especially in the context of AI.
OpenAI heads into a price war ahead of an IPO?
📆Will the ECB hike strengthen the euro?
Daily Summary: Stocks and gold on their knees as US will continue strikes on Iran (10.06.2026)
The conflict in Iran does not have to end
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.